FMP
NEXGEL, Inc.
NXGL
NASDAQ
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
2.21 USD
-0.12 (-5.43%)
About
ceo
Mr. Adam R. Levy
sector
Healthcare
industry
Medical - Instruments & Supplies
website
https://nexgel.com
exchange
NASDAQ
Description
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
CIK
0001468929
ISIN
US65344E1073
CUSIP
65344E107
Address
2150 Cabot Boulevard West
Phone
215 702 8550
Country
US
Employee
19
IPO Date
Dec 22, 2021
Key Executives
